Provided by Tiger Trade Technology Pte. Ltd.

Mangoceuticals, Inc.

0.4543
+0.01062.39%
Volume:175.02K
Turnover:77.97K
Market Cap:9.80M
PE:-0.41
High:0.4543
Open:0.4350
Low:0.4350
Close:0.4437
52wk High:2.75
52wk Low:0.1620
Shares:21.57M
Float Shares:17.60M
Volume Ratio:0.35
T/O Rate:0.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0976
EPS(LYR):-2.1664
ROE:-95.10%
ROA:-46.97%
PB:0.78
PE(LYR):-0.21

Loading ...

Oct 01, 2026

Major Issues Report

Form 8-K - Current report
Aug 21, 2026

Major Issues Report

Form 8-K - Current report
Aug 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Aug 06, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Aug 05, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Aug 05, 2026

Major Issues Report

Form 8-K - Current report
Jul 30, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 30, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 30, 2026

Major Issues Report

Form 8-K - Current report
Jul 10, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 03, 2026

Major Issues Report

Form 8-K - Current report
May 20, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 01, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 18, 2026

Major Issues Report

Form 8-K - Current report
Feb 24, 2026

Major Issues Report

Form 8-K - Current report
Feb 20, 2026

Major Issues Report

Form 8-K - Current report
Feb 06, 2026

Major Issues Report

Form 8-K - Current report
Jan 26, 2026

Correspondence

Form CORRESP - Correspondence
Jan 23, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]